NewsCase.com Financial Intelligence
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks
Menu
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks

Search NewsCase

HomeHydrogen

Hydrogen

  • AI & Quantum Computing
  • Analysis
  • Anime
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds

    Nel ASA’s Electrolyzer Leap Fails to Close the Order Gap as Shares Tumble 26%

    Analysis June 6, 2026

    Plug Power’s June Pivot: Board Exit, Asset Monetization, and AGM Put the Stock to the Test

    Analysis June 5, 2026

    ITM Power: The State’s £86.5M Bet on Chronos Meets a Market Patience Test on Cromarty

    Hydrogen June 5, 2026

    Nel ASA’s Institutional Backing and Next-Gen Electrolyzer Face Commercial Test in July

    European Markets June 3, 2026

    ITM Power: £215m in Liquidity Gives It Staying Power, but June Is the Real Exam

    European Markets June 2, 2026

    Ballard Power’s Rally Defies Weichai’s Massive Share Sale as Hydrogen Sentiment Heats Up

    Hydrogen May 30, 2026

    Nel ASA’s Rally Defies Dwindling Orders as New Products Promise Lower Costs and Better Financing

    Analysis May 30, 2026

    ITM Power Navigates Twin Political Fronts: EU Lobbying and UK State Backing

    European Markets May 29, 2026
    1...789...27Page 8 of 27

    About NewsCase

    Professional financial news and analysis for active traders and investors. We cover global markets, stocks, cryptocurrencies, and investment strategies with in-depth research and real-time market data.

    Recent News

    • Vonovia's Valuation Puzzle Deepens: A €55 Million Sale That Speaks Volumes
    • Micron's Split Screen: Record Backlog Meets a Wall Street Reality Check
    • Tempus AI's Rally Rests on a Vaccine Catalyst — and a Not-Yet-Completed Deal
    • Nvidia's Two-Front Gamble: Raising Server Prices While Backstopping a $105 Billion AI Buildout
    • Novo Nordisk's Balancing Act: A Failed Heart Study, a Legal Win, and a Quiet Bet on Smaller Doses

    Categories

    • AI & Quantum Computing
    • Analysis
    • Banking & Insurance
    • Defense & Aerospace

    Company Info

    DNV Media GmbH

    Bornheimer Str. 180
    53119 Bonn, Germany
    Phone: +49 (0) 228 28627461
    Email: info@newscase.com

    Privacy Policy Terms of Service Imprint Disclaimer Contact

    © 2026 NewsCase.com · DNV Media GmbH